New book by Larry Connors Click here Improve your trading - See how
The ability to make informed responses to RAC requests is vitally important to health care institutions," said Richard Mahoney, MedPlus president and vice president of Healthcare Information Solutions for Quest Diagnostics. "ChartMaxx V5.5 with RAC Manager empowers health enterprises with a fully integrated system and proven tools that helps them to extract the data they need to manage the RAC process effectively."
ChartMaxx V5.5 RAC Manager integrates workflows and reporting tools and deals with every step in the RAC process from pro-active data mining to reactive steps including disclosing documents from medical records, tracking all levels of the appeals process and providing graphical reports to identify the hospital's risk. The solution provides reliable data for strategic decision making, and reporting tools and e-mail alerts make the potentially numerous processes transparent so productivity issues can be effectively addressed. The RAC Manager provides a pre-built Intelligent e-Form with reports including dashboards, document types, workflow and work lists to enable transparency and tracking for each step of the RAC process.
"Hospitals across the country are actively searching for ways to handle what is a detailed multi-step auditing and appeals process," said Marcia Matthias, corporate director of Health Information for Southern Illinois Healthcare. "With just 45 days to receive, process and return potentially hundreds of records, effective management of RAC audit requests becomes especially critical. If a hospital misses a RAC deadline, overpayment is presumed without an option to appeal. ChartMaxx V5.5 with RAC Manager has our enterprise positioned very well to absorb the requests into our workflow, act swiftly during the appeals process and gain valuable insight into the steps we can take to streamline processes and refine training procedures, potentially reducing the need for future audits."
New Enhancements Grow ChartMaxx V5.5 Capabilities
ChartMaxx V5.5 includes eForms, reporting, workflow, work lists, and release of information - all fully integrated tools that are proven technologies that can be used for many other purposes across the enterprise. ChartMaxx V5.5 optimizes workflow by efficiently collecting, accessing and using clinical, financial and administrative information. ChartMaxx provides authorized users with immediate, concurrent access to records captured from scanned documents, interfaced documents, and discrete data. It facilitates access to available patient information within the organization through one system with one login and customized work lists to automatically route tasks to the right people at the right time. ChartMaxx also integrates seamlessly with the MedPlus Centergy(TM) suite, which enables clinicians to access patient data in a centralized view aggregated from multiple care sites.
Another enhancement to ChartMaxx version 5.5 requires users to provide a password entry for all signature deficiencies. Previously, ChartMaxx only required a clinician to provide a signature password for the first signature deficiency completed during a session of ChartMaxx Completion. This enhancement helps ChartMaxx V5.5 achieve compliance with the FDA digital signing requirements where an entry must be made for each signature performed while allowing sites to still use the legacy functionality of only one password entry per session wherever appropriate. Other enhancements include additions to Workflow Operator Activity Settings, the ROI viewer, Canadian French language support, and additional Intelligent eForms operating system support of Windows Vista and support for Internet Explorer 8.
For more information about ChartMaxx and other MedPlus solutions, visit www.MedPlus.com.
About MedPlus
MedPlus, based in Cincinnati, Ohio, is the healthcare information technology subsidiary of Quest Diagnostics(R). MedPlus is a leading developer and integrator of clinical connectivity and healthcare information exchange solutions that foster better patient care and improve business performance for healthcare institutions, physicians and patients. The company's Centergy Clinical Portal & Data Exchange Engine and ChartMaxx(R) solutions efficiently and securely collect, store, manage and integrate clinical information within an organization, enterprise, practice or community. Centergy enables clinicians to access patient data in a centralized view aggregated from multiple care sites. ChartMaxx, the award-winning electronic patient record system, has been implemented in more than 100 hospitals and integrated healthcare delivery networks and has more than 300,000 users. For more information, visit www.MedPlus.com.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.QuestDiagnostics.com.
(1) KLAS Confidential Information. A(C) 2009 KLAS Enterprises, LLC. All rights reserved.
Contacts:
Barb Short (Media): 973-520-2800
Kathleen Valentine (Investors): 973-520-2900
SOURCE Quest Diagnostics
http://www.questdiagnostics.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
